UBS Group’s Acacia Research ACTG Stock Holding History

UBS Group’s Portfolio ACTG Stock Details ACTG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-3,300	Closed	-$56K	–	8725
2014 Q4	$56K	Buy	+3,300	New	+$57.1K	﹤0.01%	6348

Other funds holding ACTG

Starboard Value New York $4.52B AUM 19.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return

PLC

Peapod Lane Capital Bedford Hills, New York $148M AUM 89.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS Group's ACTG Position: Q2 2026 in Review

UBS Group increased its Acacia Research (ACTG) stake by 9.1% in Q2 2026, buying an estimated $50.8K and bringing the position to 126,649 shares worth $590K. The position accounts for ﹤0.01% of the portfolio, ranked #6125.

UBS Group first reported a position in ACTG in Q4 2014 and has held it in 44 quarters since. 123 funds tracked by Wall St. Rank hold ACTG as of Q2 2026.

UBS Group held 126,649 shares of Acacia Research worth $590K as of Q2 2026.
UBS Group bought 10,577 Acacia Research shares in Q2 2026, an estimated $50.8K.
Acacia Research made up ﹤0.01% of UBS Group's portfolio in Q2 2026, its #6125 holding.
UBS Group first reported a position in Acacia Research in Q4 2014 and has held it in 44 quarters since.
123 funds tracked by Wall St. Rank held Acacia Research as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.